Global Perfusion Bioreactors Market to reach USD XX billion by 2027.
Global Perfusion Bioreactors Market is valued at approximately USD XX million in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. The adoption of capital-intensive combination technologies is being fueled by increased spending in life sciences R&D. In addition, technology transfer has resulted in the development of completely automated bioprocessing analyzers. Due to their high throughput and efficient use of limited resources, manufacturers have increased their usage of bioprocess equipment. Technology transfers have a significant influence on biopharmaceutical businesses in emerging economies, as they boost production capacity and lower costs. Several key manufacturers are taking strategic initiatives to expand their presence in the market. For instance, in February 2021, Thermo Fisher Scientific acquired Mesa Biotech, a privately held point-of-care molecular diagnostic company. Similarly, Sartorius completed the acquisition of Danaher Corporation's selected life science operations in 2020. However, cost of perfusion bioreactors is very high which may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Perfusion Bioreactors Market is considered for the key regions such as Europe, North America, Asia Pacific, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to increasing research & development (R&D) of novel biologics and new approvals of biological products in the region. Whereas Europe is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to increasing adoption of perfusion bioreactors for industrial product manufacturing for products in the U.K.
Major market player included in this report are:

Sartorius AG
Cell Culture Company
Cytiva (Danaher Corporation)
CELLEC BIOTEK AG
Synthecon Inc
Getinge (Applikon Biotechnology B.V)
Zellwerk GmbH
Thermo Fisher Scientific Inc
Eppendorf AG
Infors HT
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Small Scale(50 litres to 1,000 litres)
Large Scale(>1,000 litres)
By Application:
Biopharmaceutical Companies
Biotechnology Companies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018-19
Base year - 2019-2020
Forecast period - 2021 to 2027.

Target Audience of the Global Perfusion Bioreactors Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors